Novel diagnostics may be a cost-effective intervention for sepsis management to reduce bed days and reduce inappropriate prescribing of antibiotics.

Sepsis is a life-threatening condition in response to infection. Without rapid treatment, sepsis can result in tissue damage, organ failure or death. Speed is of the essence for sepsis management and faster diagnosis of specific pathogens may help ensure patients receive the most appropriate treatments as soon as possible. Reducing the use of broad-spectrum antibiotics is an essential part of antibiotic stewardship to prevent the emergence of antibiotic resistance. This work explored the potential use of a novel diagnostic test to rapidly detect sepsis-causing pathogens including Gram-negative or Gram-positive bacterial or fungal infections and to aid in the diagnosis of sepsis in severely ill, hospitalised adult patients.  

Continue reading